Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Inhalation of Interleukin-2 (IL-2) in Patients With Metastatic or Unresectable Cancer

NCT00003009 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT00003009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Inhalation of Interleukin-2 (IL-2) in Patients With Metastatic or Unresectable Cancer
Lead sponsor
University of Southern California
Phase
Phase 1
Overall status
Terminated
Start date
February 29, 1996
Completion date
August 31, 2000
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific